Features | Partner Sites | Information | LinkXpress
Sign In
FLUKE BIOMEDICAL
SCHILLER AG
Advantech Europe

Innovative Gastroscope Enhances Imaging Capabilities

By HospiMedica International staff writers
Posted on 21 Nov 2013
Image: The tip of the Fuse 1G Gastroscope (Photo courtesy of EndoChoice).
Image: The tip of the Fuse 1G Gastroscope (Photo courtesy of EndoChoice).
A flexible endoscope with an extended 245-degree field of view facilitates diagnoses in the upper gastrointestinal (GI) tract.

The Fuse 1G Gastroscope employs Full Spectrum Endoscopy technology using two cameras, while traditional systems have just one camera. This allows observation of nearly twice as much surface area, allowing clinicians to identify adenomas or precancerous lesions in and behind the folds that occur naturally in the colon and stomach anatomy, problem areas that can easily go undetected when using traditional endoscopes. Optimal imaging is enabled using built-in light emitting diode (LED) lighting around the tip to provide illumination.

Images are displayed on three high-definition (HD) screens, allowing visualization of more of the GI tract. The system uses a FuseBox control unit with the FusePanel image management system to interface with electronic medical record (EMR) systems for tracking of patients, physician IDs, and the procedures performed. It also enables saving of every image for viewing or printing later. Images can be captured remotely or can be exported in PDF format to be used on other EMR systems. The Fuse 1G Gastroscope is a product of EndoChoice (Atlanta, GA, USA), and has been approved by the US Food and Drug Administration (FDA).

“We are 100% focused on serving the GI professionals so they can give the best possible care to their patients,” said Mark Gilreath, founder and CEO of EndoChoice. “This clearance by the FDA is yet another milestone in our efforts to make the Fuse system available to more hospitals and clinics.”

“We have a national colorectal cancer screening program in the United States wherein most people should get screened for colorectal cancer, but not all patients follow these guidelines,” said Prof. Douglas K. Rex, MD, of Indiana University (Indianapolis, USA). “The data from the Full Spectrum Endoscopy Tandem study would indicate that Fuse is a radical improvement over the tools we've used in the past to fight GI disease.”

Related Links:

EndoChoice


Channels

Women's Health

view channel

Low-Dose Aspirin Will Not Prevent Pregnancy Loss

A new study reveals that in general, low-dose aspirin is not beneficial for future pregnancy outcomes in women with prior pregnancy loss. Researchers at the University at Buffalo (NY, USA) conducted a placebo-controlled trial that included 1,228 women (aged 18-40 years) who were attempting to become pregnant.... Read more

Hospital News

view channel
Image: Artist’s rendering of the Royal Edinburgh Hospital redevelopment (Photo courtesy of the NHS Lothian).

Scottish Government Approves Royal Edinburgh Hospital Redevelopment

NHS Lothian (Edinburgh, United Kingdom) has received approval from the Scottish Government for the GBP 48 million, first phase of the Royal Edinburgh Hospital (REH) development. Work to prepare the... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.